https://doctransparency.com/doctor/tx/houston/alice-mao-1851309488
Medicare Enrolled

Dr. Alice Mao, MD

Child & Adolescent Psychiatry Physician · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
550 WESTCOTT ST, Houston, TX 77007
7138646694
In practice since 2006 (19 years)
NPI: 1851309488 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mao? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mao

Dr. Alice Mao is a child & adolescent psychiatry physician in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Mao performed 133 Medicare services across 49 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mao received a total of $879,476 from 47 pharmaceutical and/or device companies across 1829 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in child & adolescent psychiatry physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mao is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 40% volume in TX$ $879,476 industry payments

Medicare Practice Summary

Medicare Utilization ↗
133
Medicare services
Top 40% in TX for child & adolescent psychiatry physician
49
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)77$70$155
Psychotherapy with evaluation and management visit, 30 minutes56$44$85
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$879,476
Total received (2018-2024)
Avg $125,639/year across 7 years
Top 1% in TX for child & adolescent psychiatry physician
47
Companies
1,829
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$826,980 (94.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$40,811 (4.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,685 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$129,350
2023
$171,732
2022
$113,082
2021
$82,633
2020
$21,065
2019
$161,931
2018
$199,683

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$172,639
Supernus Pharmaceuticals, Inc.
$168,432
Tris Pharma Inc
$151,547
Corium, LLC
$126,874
Sunovion Pharmaceuticals Inc.
$91,111
Teva Pharmaceuticals USA, Inc.
$35,352
Corium, Inc.
$32,197
Neos Therapeutics, LP
$27,630
Adlon Therapeutics L.P.
$24,249
Takeda Pharmaceuticals U.S.A., Inc.
$17,140
Shire North American Group Inc
$5,991
Allergan Inc.
$5,470
Ironshore Pharmaceuticals Inc.
$5,247
Janssen Pharmaceuticals, Inc
$4,078
Axsome Therapeutics, Inc.
$2,179
Aytu BioPharma, Inc.
$1,898
Lundbeck LLC
$898
ABBVIE INC.
$891
Otsuka Pharmaceutical Development & Commercialization, Inc.
$851
Bausch Health US, LLC
$783
Neurocrine Biosciences, Inc.
$749
Purdue Pharma L.P.
$349
Validus Pharmaceuticals LLC
$312
ITI, Inc.
$305
Vanda Pharmaceuticals Inc.
$258
Neuronetics, Inc.
$237
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$208
Allergan, Inc.
$194
AbbVie Inc.
$172
Alkermes, Inc.
$168
ARBOR PHARMACEUTICALS, INC.
$167
JAZZ PHARMACEUTICALS INC.
$159
Merck Sharp & Dohme LLC
$119
Almatica Pharma LLC
$86
Avanir Pharmaceuticals, Inc.
$79
Noven Therapeutics, LLC
$69
Rhodes Pharmaceuticals L.P.
$67
Eisai Inc.
$67
Merck Sharp & Dohme Corporation
$60
Vertical Pharmaceuticals, LLC
$44
Indivior Inc.
$27
IRONSHORE PHARMACEUTICALS INC.
$24
PFIZER INC.
$23
LivaNova USA, Inc.
$23
Sun Pharmaceutical Industries Inc.
$21
Noven Pharmaceuticals, Inc.
$18
OWP Pharmaceuticals, Inc.
$16
Top 3 companies account for 56.0% of total payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COTEMPLA XR-ODT · Cotempla XR-ODT · Dayvigo · Dyanavel XR · EZALLOR SPRINKLE · Edarbi · Equetro · Evekeo · FANAPT · GRALISE · HETLIOZ · INGREZZA · INVEGA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · Lamotrigine Starter Kit · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · Nuedexta · Onyda XR · PERSERIS · QELBREE · QUILLIVANT XR · Qelbree · Quillichew ER · Quillivant · Quillivant XR · RELEXXII · REXULTI · SECUADO · SPRAVATO · SUNOSI · Secuado · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VNS - Symmetry · VRAYLAR · VYVANSE · WELLBUTRIN · WELLBUTRIN XL · Xelstrym · ZolpiMist
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in child & adolescent psychiatry physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for child & adolescent psychiatry physician in TX.

Equivalent to $661,260 per 100 Medicare services performed
Looking for a child & adolescent psychiatry physician in Houston?
Compare child & adolescent psychiatry physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse child & adolescent psychiatry physicians nearby

Geographic Context

Child & Adolescent Psychiatry Physicians within 10 mi
108
Per 100K population
2.3
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN HOSPITAL SYSTEM
1.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mao is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mao experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mao performed 77 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mao receive payments from pharmaceutical companies?
Yes. Dr. Mao received a total of $879,476 from 47 companies across 1,829 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mao's costs compare to other child & adolescent psychiatry physicians in Houston?
Dr. Mao's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →